Works matching IS 0008543X AND DT 2025 AND VI 131 AND IP 12

Results: 16
    1
    2

    Randomized phase II clinical trial of cisplatin/carboplatin and etoposide (PE) alone or in combination with nivolumab as frontline therapy for extensive‐stage small cell lung cancer (ES‐SCLC): ECOG‐ACRIN EA5161.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 12, p. 1, doi. 10.1002/cncr.35938
    By:
    • Leal, Ticiana A.;
    • Wang, Yating;
    • Dowlati, Afshin;
    • Chay, Christopher H.;
    • Chen, Yuanbin;
    • Mohindra, Amit R.;
    • Razaq, Mohammad;
    • Ajuja, Harish G.;
    • Liu, Jijun;
    • King, David M.;
    • Sumey, Christopher J.;
    • Ramalingam, Suresh S.
    Publication type:
    Article
    3
    4

    A phase 1 dual‐dose escalation study of radiation and nab‐paclitaxel in patients with unresectable and borderline resectable pancreatic cancer.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 12, p. 1, doi. 10.1002/cncr.35936
    By:
    • Amit, Uri;
    • Metz, James M.;
    • Plastaras, John P.;
    • Gheewala, Rohi;
    • Teitelbaum, Ursina;
    • Damjanov, Nevena;
    • Vollmer, Charles;
    • Schneider, Charles J.;
    • Lee, Major Kenneth;
    • O'Hara, Mark;
    • Reiss‐Binder, Kim;
    • Carpenter, Erica L.;
    • Karasic, Thomas B.;
    • Konski, Andre;
    • Wileyto, E. Paul;
    • Ben‐Josef, Edgar
    Publication type:
    Article
    5
    6
    7
    8

    Issue Information.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 12, p. 1, doi. 10.1002/cncr.35932
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16